DRIEHAUS CAPITAL MANAGEMENT LLC
Institutional investor · Portfolio as of Q1 2019
Top Holdings388 positions
ALIBABA GROUP HLDG LTD | 730,854 | $133.3M | 5.0% | $173.27 | 0.00% | 1 qtr | First report 0 |
TAIWAN SEMICONDUCTOR MANUFAC | 3.1M | $127.2M | 4.8% | $34.76 | 0.00% | 1 qtr | First report 0 |
HDFC BANK LTD | 725,845 | $84.1M | 3.2% | $26.73 | 0.00% | 1 qtr | First report 0 |
ICICI BK LTD | 6.4M | $73M | 2.7% | $11.05 | 0.00% | 1 qtr | First report 0 |
PETROLEO BRASILEIRO S A | 2.8M | $45M | 1.7% | $4.56 | 0.00% | 1 qtr | First report 0 |
| 1.8M | $44.1M | 1.7% | — | — | 1 qtr | First report 0 | |
ARGENX SE | 325,930 | $40.7M | 1.5% | $124.84 | 0.00% | 1 qtr | First report 0 |
Credicorp LTD | 153,937 | $36.9M | 1.4% | $154.88 | 0.00% | 1 qtr | First report 0 |
EVERBRIDGE INC | 488,684 | $36.7M | 1.4% | — | — | 1 qtr | First report 0 |
STANDARD BIOTOOLS INC | 2.5M | $33.5M | 1.3% | $13.29 | 0.00% | 1 qtr | First report 0 |
LIBERTY MEDIA CORP-LIBERTY-C | 950,986 | $33.3M | 1.3% | $32.59 | 0.00% | 1 qtr | First report 0 |
NIKE INC | 386,359 | $32.5M | 1.2% | $75.08 | 0.00% | 1 qtr | First report 0 |
MYOKARDIA INC | 603,974 | $31.4M | 1.2% | — | — | 1 qtr | First report 0 |
Tandem Diabetes Care Inc New | 483,719 | $30.7M | 1.2% | $63.50 | 0.00% | 1 qtr | First report 0 |
ALTERYX INC - CLASS A | 359,004 | $30.1M | 1.1% | — | — | 1 qtr | First report 0 |
INSPIRE MED SYS INC | 519,589 | $29.5M | 1.1% | $56.78 | 0.00% | 1 qtr | First report 0 |
FIVE9 INC | 553,259 | $29.2M | 1.1% | $52.83 | 0.00% | 1 qtr | First report 0 |
HUYA INC | 1M | $28.8M | 1.1% | $10.69 | 0.00% | 1 qtr | First report 0 |
BANDWIDTH INC | 394,877 | $26.4M | 1.0% | $66.96 | 0.00% | 1 qtr | First report 0 |
MERCADOLIBRE INC | 49,375 | $25.1M | 0.9% | $507.73 | 0.00% | 1 qtr | First report 0 |
DRIEHAUS CAPITAL MANAGEMENT LLC manages $2.7B across 388 positions as of Q1 2019. Top holdings: BABA (5.0%), TSM (4.8%), HDB (3.2%). Fund DNA: Diversified Scout. HoldingsIntel Score: 1.5/5.0.
First quarter we have for this fund: 388 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $2.7B across 388 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR